세계의 온보디 인젝터 시장 : 분석과 예측(2018-2029년)

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global On-body Injectors market was valued at US$ 143.67 million in 2022 and will reach US$ 358.98 million by the end of 2029, growing at a CAGR of 15.00% during 2023-2029.

North American market for On-body Injectors was valued at $ 75.86 million in 2022 and will reach $ 188.15 million by 2029, at a CAGR of 14.46% during the forecast period of 2023 through 2029.

Asia-Pacific market for On-body Injectors was valued at $ 13.97 million in 2022 and will reach $ 38.19 million by 2029, at a CAGR of 17.00% during the forecast period of 2023 through 2029.

Europe market for On-body Injectors was valued at $ 49.61 million in 2022 and will reach $ 122.49 million by 2029, at a CAGR of 15.31% during the forecast period of 2023 through 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for On-body Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding On-body Injectors.

The On-body Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global On-body Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global On-body Injectors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the On-body Injectors segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

• West Pharmaceutical Services
• Insulet
• Gerresheimer
• United Therapeutics
• CC Bio
• BD
• Ypsomed
• Enable Injections
• Nemera
• Stevanato Group
• Sonceboz
• Lohmann Therapie-Systeme
• Elcam Drug Delivery Devices (E3D)

Segment by Type

• Electronic Injectors
• Mechanical Injectors

Segment by Application

• Immuno-oncology
• Cardiovascular Diseases
• Neurological Diseases
• Others

By Region

• North America
  • United States
  • Canada

• Asia-Pacific
  • China
  • Japan
  • South Korea
  • China Taiwan
  • India
  • Southeast Asia

• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Switzerland

• Latin America, Middle East and Africa
  • Brazil
  • Israel
  • Turkey

Core Chapters

• Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East and Africa, Middle East & Africa.

• Chapter Two: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

• Chapter Three: Sales, revenue of On-body Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

• Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East and Africa, Middle East & Africa.

• Chapter Five, Six, Seven and Eight: North America, Europe, Asia Pacific, Latin America, Middle East and Africa, sales and revenue by country.

• Chapter Nine: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

• Chapter Ten: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

• Chapter Eleven: Analysis of sales channel, distributors and customers.

• Chapter Twelve: Research Findings and Conclusion.

Table of Contents

1 On-body Injectors Market Overview

• 1.1 On-body Injectors Product Overview
• 1.2 On-body Injectors Market by Type
  • 1.2.1 Electronic Injectors
  • 1.2.2 Mechanical Injectors
• 1.3 Global On-body Injectors Market Size by Type
  • 1.3.1 Global On-body Injectors Market Size Overview by Type (2018-2029)
  • 1.3.2 Global On-body Injectors Historic Market Size Review by Type (2018-2023)
  • 1.3.3 Global On-body Injectors Forecasted Market Size by Type (2024-2029)
• 1.4 Key Regions Market Size by Type
  • 1.4.1 North America On-body Injectors Sales Breakdown by Type (2018-2029)
  • 1.4.2 Europe On-body Injectors Sales Breakdown by Type (2018-2029)
  • 1.4.3 Asia-Pacific On-body Injectors Sales Breakdown by Type (2018-2029)
  • 1.4.4 Latin America, Middle East and Africa On-body Injectors Sales Breakdown by Type (2018-2029)

2 On-body Injectors Market Competition by Company

• 2.1 Global Top Players by On-body Injectors Sales (2018-2023)
• 2.2 Global Top Players by On-body Injectors Revenue (2018-2023)
• 2.3 Global Top Players by On-body Injectors Price (2018-2023)
• 2.4 Global Top Manufacturers On-body Injectors Manufacturing Base Distribution, Sales Area, Product Type
• 2.5 On-body Injectors Market Competitive Situation and Trends
  • 2.5.1 On-body Injectors Market Concentration Rate (2018-2023)
  • 2.5.2 Global 3 and 5 Largest Manufacturers by On-body Injectors Revenue in 2022
• 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2022)
• 2.7 Date of Key Manufacturers Enter into On-body Injectors Market
• 2.8 Mergers & Acquisitions, Expansion

3 On-body Injectors Status and Outlook by Region

• 3.1 Global On-body Injectors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
• 3.2 Global On-body Injectors Historic Market Size by Region
  • 3.2.1 Global On-body Injectors Sales in Volume by Region (2018-2023)
  • 3.2.2 Global On-body Injectors Sales in Value by Region (2018-2023)
  • 3.2.3 Global On-body Injectors Sales (Volume & Value), Price and Gross Margin (2018-2023)
• 3.3 Global On-body Injectors Forecasted Market Size by Region
  • 3.3.1 Global On-body Injectors Sales in Volume by Region (2024-2029)
  • 3.3.2 Global On-body Injectors Sales in Value by Region (2024-2029)
  • 3.3.3 Global On-body Injectors Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 On-body Injectors by Application

• 4.1 On-body Injectors Market by Application
  • 4.1.1 Immuno-oncology
  • 4.1.2 Cardiovascular Diseases
  • 4.1.3 Neurological Diseases
  • 4.1.4 Others
• 4.2 Global On-body Injectors Market Size by Application
  • 4.2.1 Global On-body Injectors Market Size Overview by Application (2018-2029)
  • 4.2.2 Global On-body Injectors Historic Market Size Review by Application (2018-2023)
  • 4.2.3 Global On-body Injectors Forecasted Market Size by Application (2024-2029)
• 4.3 Key Regions Market Size by Application
  • 4.3.1 North America On-body Injectors Sales Breakdown by Application (2018-2023)
  • 4.3.2 Europe On-body Injectors Sales Breakdown by Application (2018-2023)
  • 4.3.3 Asia-Pacific On-body Injectors Sales Breakdown by Application (2018-2023)
  • 4.3.4 Latin America, Middle East and Africa On-body Injectors Sales Breakdown by Application (2018-2023)

5 North America On-body Injectors by Country

• 5.1 North America On-body Injectors Historic Market Size by Country
  • 5.1.1 North America On-body Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 5.1.2 North America On-body Injectors Sales in Volume by Country (2018-2023)
  • 5.1.3 North America On-body Injectors Sales in Value by Country (2018-2023)
• 5.2 North America On-body Injectors Forecasted Market Size by Country
  • 5.2.1 North America On-body Injectors Sales in Volume by Country (2024-2029)
  • 5.2.2 North America On-body Injectors Sales in Value by Country (2024-2029)

6 Europe On-body Injectors by Country

• 6.1 Europe On-body Injectors Historic Market Size by Country
  • 6.1.1 Europe On-body Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 6.1.2 Europe On-body Injectors Sales in Volume by Country (2018-2023)
  • 6.1.3 Europe On-body Injectors Sales in Value by Country (2018-2023)
• 6.2 Europe On-body Injectors Forecasted Market Size by Country
  • 6.2.1 Europe On-body Injectors Sales in Volume by Country (2024-2029)
  • 6.2.2 Europe On-body Injectors Sales in Value by Country (2024-2029)

7 Asia-Pacific On-body Injectors by Region

• 7.1 Asia-Pacific On-body Injectors Historic Market Size by Region
  • 7.1.1 Asia-Pacific On-body Injectors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
  • 7.1.2 Asia-Pacific On-body Injectors Sales in Volume by Region (2018-2023)
  • 7.1.3 Asia-Pacific On-body Injectors Sales in Value by Region (2018-2023)
• 7.2 Asia-Pacific On-body Injectors Forecasted Market Size by Region
  • 7.2.1 Asia-Pacific On-body Injectors Sales in Volume by Region (2024-2029)
  • 7.2.2 Asia-Pacific On-body Injectors Sales in Value by Region (2024-2029)

8 Latin America, Middle East and Africa On-body Injectors by Country

• 8.1 Latin America, Middle East and Africa On-body Injectors Historic Market Size by Country
  • 8.1.1 Latin America, Middle East and Africa On-body Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 8.1.2 Latin America, Middle East and Africa On-body Injectors Sales in Volume by Country (2018-2023)
  • 8.1.3 Latin America, Middle East and Africa On-body Injectors Sales in Value by Country (2018-2023)
• 8.2 Latin America, Middle East and Africa On-body Injectors Forecasted Market Size by Country
  • 8.2.1 Latin America, Middle East and Africa On-body Injectors Sales in Volume by Country (2024-2029)
  • 8.2.2 Latin America, Middle East and Africa On-body Injectors Sales in Value by Country (2024-2029)

9 Company Profiles

• 9.1 West Pharmaceutical Services
  • 9.1.1 West Pharmaceutical Services Company Information
  • 9.1.2 West Pharmaceutical Services Introduction and Business Overview
  • 9.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
  • 9.1.4 West Pharmaceutical Services On-body Injectors Products Offered
  • 9.1.5 West Pharmaceutical Services Recent Development
• 9.2 Insulet
  • 9.2.1 Insulet Company Information
  • 9.2.2 Insulet Introduction and Business Overview
  • 9.2.3 Insulet On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
  • 9.2.4 Insulet On-body Injectors Products Offered
  • 9.2.5 Insulet Recent Development
• 9.3 Gerresheimer
  • 9.3.1 Gerresheimer Company Information
  • 9.3.2 Gerresheimer Introduction and Business Overview
  • 9.3.3 Gerresheimer On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
  • 9.3.4 Gerresheimer On-body Injectors Products Offered
• 9.4 United Therapeutics
  • 9.4.1 United Therapeutics Company Information
  • 9.4.2 United Therapeutics Introduction and Business Overview
  • 9.4.3 United Therapeutics On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
  • 9.4.4 United Therapeutics On-body Injectors Products Offered
• 9.5 CC Bio
  • 9.5.1 CC Bio Company Information
  • 9.5.2 CC Bio Introduction and Business Overview
  • 9.5.3 CC Bio On-body Injectors Sales, Revenue and Gross Margin (2018-2023)
  • 9.5.4 CC Bio On-body Injectors Products Offered
• 9.6 BD
  • 9.6.1 BD Company Information
  • 9.6.2 BD Introduction and Business Overview
  • 9.6.3 BD On-body Injectors Products Offered
  • 9.6.4 BD Recent Development
• 9.7 Ypsomed
  • 9.7.1 Ypsomed Company Information
  • 9.7.2 Ypsomed Introduction and Business Overview
  • 9.7.3 Ypsomed On-body Injectors Products Offered
  • 9.7.4 Ypsomed Recent Development
• 9.8 Enable Injections
  • 9.8.1 Enable Injections Company Information
  • 9.8.2 Enable Injections Introduction and Business Overview
  • 9.8.3 Enable Injections On-body Injectors Products Offered
  • 9.8.4 Enable Injections Recent Development
• 9.9 Nemera
  • 9.9.1 Nemera Company Information
  • 9.9.2 Nemera Introduction and Business Overview
  • 9.9.3 Nemera On-body Injectors Products Offered
• 9.10 Stevanato Group
  • 9.10.1 Stevanato Group Company Information
  • 9.10.2 Stevanato Group Introduction and Business Overview
  • 9.10.3 Stevanato Group On-body Injectors Products Offered
  • 9.10.4 Stevanato Group Recent Development
• 9.11 Sonceboz
  • 9.11.1 Sonceboz Company Information
  • 9.11.2 Sonceboz Introduction and Business Overview
  • 9.11.3 Sonceboz On-body Injectors Products Offered
• 9.12 Lohmann Therapie-Systeme
  • 9.12.1 Lohmann Therapie-Systeme Company Information
  • 9.12.2 Lohmann Therapie-Systeme Introduction and Business Overview
  • 9.12.3 Lohmann Therapie-Systeme On-body Injectors Products Offered
  • 9.12.4 Lohmann Therapie-Systeme Recent Development
• 9.13 Elcam Drug Delivery Devices (E3D)
  • 9.13.1 Elcam Drug Delivery Devices (E3D) Company Information
  • 9.13.2 Elcam Drug Delivery Devices (E3D) Introduction and Business Overview
  • 9.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Products Offered

10 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

• 10.1 On-body Injectors Key Raw Materials
  • 10.1.1 Key Raw Materials
  • 10.1.2 Raw Materials Key Suppliers
• 10.2 Manufacturing Cost Structure
  • 10.2.1 Raw Materials
  • 10.2.2 Labor Cost
  • 10.2.3 Manufacturing Expenses
• 10.3 On-body Injectors Industrial Chain Analysis
• 10.4 On-body Injectors Market Dynamics
  • 10.4.1 On-body Injectors Industry Trends
  • 10.4.2 On-body Injectors Market Drivers
  • 10.4.3 On-body Injectors Market Challenges and Restraints

11 Marketing Strategy Analysis, Distributors

• 11.1 Sales Channel
• 11.2 On-body Injectors Distributors
• 11.3 On-body Injectors Downstream Customers

12 Research Findings and Conclusion

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer